SlideShare une entreprise Scribd logo
1  sur  6
Find Industry reports, Company profiles
ReportLinker                                                                          and Market Statistics
                                               >> Get this Report Now by email!



Epistem Holdings Plc ' Product Pipeline Review ' 2012
Published on December 2012

                                                                                                              Report Summary

Epistem Holdings Plc ' Product Pipeline Review ' 2012


Summary


Global Market Direct's pharmaceuticals report, "Epistem Holdings Plc - Product Pipeline Review - 2012" provides data on the Epistem
Holdings Plc's research and development focus. The report includes information on current developmental pipeline, complete with
latest updates, and features on discontinued and dormant projects.


This report is built using data and information sourced from Global Markets Direct's proprietary databases, Epistem Holdings Plc's
corporate website, SEC filings, investor presentations and featured press releases, both from Epistem Holdings Plc and
industry-specific third party sources, put together by Global Markets Direct's team.


Scope


- Epistem Holdings Plc - Brief Epistem Holdings Plc overview including business description, key information and facts, and its
locations and subsidiaries.
- Review of current pipeline of Epistem Holdings Plc human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities,
across the globe.
- Product profiles for late stage and clinical stage products of Epistem Holdings Plc with complete description of the product's
developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Epistem Holdings Plc's pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.


Reasons to buy


- Evaluate Epistem Holdings Plc's strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Epistem Holdings Plc in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Epistem Holdings Plc's R&D portfolio and develop key strategic initiatives to
reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Epistem Holdings Plc.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Epistem Holdings Plc and identify potential opportunities in those areas.




Epistem Holdings Plc ' Product Pipeline Review ' 2012 (From Slideshare)                                                            Page 1/6
Find Industry reports, Company profiles
ReportLinker                                                                     and Market Statistics
                                               >> Get this Report Now by email!



                                                                                                Table of Content

Table of Contents


Table of Contents 2
List of Tables 4
List of Figures 4
Epistem Holdings Plc Snapshot 5
Epistem Holdings Plc Overview 5
Key Information 5
Key Facts 5
Epistem Holdings Plc ' Research and Development Overview 6
Key Therapeutic Areas 6
Epistem Holdings Plc ' Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products ' Monotherapy 9
Epistem Holdings Plc ' Pipeline Products Glance 10
Epistem Holdings Plc ' Early Stage Pipeline Products 10
Pre-Clinical Products/Combination Treatment Modalities 10
Epistem Holdings Plc ' Drug Profiles 11
Epi-2221 11
Product Description 11
Mechanism of Action 11
R&D Progress 11
Epi-288 12
Product Description 12
Mechanism of Action 12
R&D Progress 12
Epi-3905 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
Epi-6 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
Epistem Holdings Plc ' Pipeline Analysis 15
Epistem Holdings Plc ' Pipeline Products by Therapeutic Class 15
Epistem Holdings Plc ' Company Statement 16
Epistem Holdings Plc ' Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Financial Deals Landscape 19
Epistem Holdings Plc, Deals Summary 19
Epistem Holdings Plc, Pharmaceuticals & Healthcare, Deal Details 20
Partnerships 20



Epistem Holdings Plc ' Product Pipeline Review ' 2012 (From Slideshare)                                     Page 2/6
Find Industry reports, Company profiles
ReportLinker                                                                     and Market Statistics
                                               >> Get this Report Now by email!

Epistem Enters Into Distribution Agreement With Becton Dickinson For Mycobacterium TB Test 20
Epistem Holdings Enters Into Co-Development Agreement With GlaxoSmithKline 21
Epistem Holdings Enters Into Co-Marketing Agreement With Xcelris Labs For Molecular Tuberculosis Diagnostic Test 22
EpiStem Enters Into Research And Development Agreement With Novartis 23
Kyowa Hakko Kirin Enters Into Co-Development Agreement With Epistem 25
Equity Offering 26
Epistem Announces Private Placement Of Shares For $7 Million 26
Epistem Holdings Completes Private Placement Of Common Stock For $4.3 Million 28
Epistem Raises $5 Million In Private Financing 30
Epistem Holdings Completes Private Placement Of $2 Million 32
Epistem Holdings Completes IPO For $6.12 Million 34
Appendix 36
Methodology 36
Coverage 36
Secondary Research 36
Primary Research 36
Expert Panel Validation 36
Contact Us 37
Disclaimer 37




List of Tables


Epistem Holdings Plc, Key Information 5
Epistem Holdings Plc, Key Facts 5
Epistem Holdings Plc ' Pipeline by Indication, 2012 7
Epistem Holdings Plc ' Pipeline by Stage of Development, 2012 8
Epistem Holdings Plc ' Monotherapy Products in Pipeline, 2012 9
Epistem Holdings Plc ' Pre-Clinical, 2012 10
Epistem Holdings Plc ' Pipeline By Therapeutic Class, 2012 15
Epistem Holdings Plc, Subsidiaries 18
Epistem Holdings Plc, Deals Summary 19
Epistem Enters Into Distribution Agreement With Becton Dickinson For Mycobacterium TB Test 20
Epistem Holdings Enters Into Co-Development Agreement With GlaxoSmithKline 21
Epistem Holdings Enters Into Co-Marketing Agreement With Xcelris Labs For Molecular Tuberculosis Diagnostic Test 22
EpiStem Enters Into Research And Development Agreement With Novartis 23
Kyowa Hakko Kirin Enters Into Co-Development Agreement With Epistem 25
Epistem Announces Private Placement Of Shares For $7 Million 26
Epistem Holdings Completes Private Placement Of Common Stock For $4.3 Million 28
Epistem Raises $5 Million In Private Financing 30
Epistem Holdings Completes Private Placement Of $2 Million 32
Epistem Holdings Completes IPO For $6.12 Million 34




List of Figures




Epistem Holdings Plc ' Product Pipeline Review ' 2012 (From Slideshare)                                               Page 3/6
Find Industry reports, Company profiles
ReportLinker                                                                     and Market Statistics
                                               >> Get this Report Now by email!

Epistem Holdings Plc ' Pipeline by Indication, 2012 7
Epistem Holdings Plc ' Pipeline by Stage of Development, 2012 8
Epistem Holdings Plc ' Monotherapy Products in Pipeline, 2012 9
Epistem Holdings Plc ' Pipeline By Therapeutic Class, 2012 15




Epistem Holdings Plc ' Product Pipeline Review ' 2012 (From Slideshare)                                     Page 4/6
Find Industry reports, Company profiles
ReportLinker                                                                              and Market Statistics
                                               >> Get this Report Now by email!
              Fax Order Form
              To place an order via fax simply print this form, fill in the information below and fax the completed form to:
                           Europe, Middle East and Africa : + 33 4 37 37 15 56
                           Asia, Oceania and America : + 1 (805) 617 17 93
              If you have any questions please visit http://www.reportlinker.com/notify/contact


              Order Information
              Please verify that the product information is correct and select the format(s) you require.

                    Epistem Holdings Plc ' Product Pipeline Review ' 2012




              Product Formats
              Please select the product formats and the quantity you require.

                                      1 User License--USD 1 500.00               Quantity: _____



                                      Site License--USD 3 000.00                 Quantity: _____



                                      Corporate License--USD 4 500.00            Quantity: _____




              Contact Information
              Please enter all the information below in BLOCK CAPITALS


              Title:                    Mr                        Mrs     Dr               Miss             Ms                 Prof

              First Name:                    _____________________________ Last Name: __________________________________

              Email Address:                __________________________________________________________________________

              Job Title:                    __________________________________________________________________________

              Organization:                 __________________________________________________________________________

              Address:                      __________________________________________________________________________

              City:                         __________________________________________________________________________

              Postal / Zip Code:             __________________________________________________________________________

              Country:                      __________________________________________________________________________

              Phone Number:                 __________________________________________________________________________

              Fax Number:                  __________________________________________________________________________




Epistem Holdings Plc ' Product Pipeline Review ' 2012 (From Slideshare)                                                               Page 5/6
Find Industry reports, Company profiles
ReportLinker                                                                                         and Market Statistics
                                               >> Get this Report Now by email!
              Payment Information
              Please indicate the payment method, you would like to use by selecting the appropriate box.




                     Payment by credit card                         Card Number: ______________________________________________


                                                                    Expiry Date     __________ / _________


                                                                    CVV Number _____________________


                                                                    Card Type (ex: Visa, Amex…) _________________________________




                     Payment by wire transfer                       Crédit Mutuel
                                                                    RIB : 10278 07314 00020257701 89
                                                                    BIC : CMCIFR2A
                                                                    IBAN : FR76 1027 8073 1400 0202 5770 189




                      Payment by check                              UBIQUICK SAS
                                                                    16 rue Grenette – 69002 LYON, FRANCE




                                   Customer signature:

                                    




              Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
              http://www.reportlinker.com/index/terms




                                                                          Please fax this form to:

                                                        Europe, Middle East and Africa : + 33 4 37 37 15 56

                                                          Asia, Oceania and America : + 1 (805) 617 17 93




Epistem Holdings Plc ' Product Pipeline Review ' 2012 (From Slideshare)                                                             Page 6/6

Contenu connexe

En vedette

Para que se usan los blogs v1
Para que se usan los blogs v1Para que se usan los blogs v1
Para que se usan los blogs v1ericortiz24
 
Understanding Preferential Allotment of Securities
Understanding Preferential Allotment of SecuritiesUnderstanding Preferential Allotment of Securities
Understanding Preferential Allotment of SecuritiesPavan Kumar Vijay
 
Curriculum Vitae 10.02.15 sea service
Curriculum Vitae 10.02.15 sea serviceCurriculum Vitae 10.02.15 sea service
Curriculum Vitae 10.02.15 sea serviceFernand Lontoh
 
Kenexa style numerical test tutorial sample
Kenexa style numerical test tutorial sampleKenexa style numerical test tutorial sample
Kenexa style numerical test tutorial sampleGraduate Monkey
 
New base 572 special 31 march 2015
New base 572 special 31 march  2015New base 572 special 31 march  2015
New base 572 special 31 march 2015Khaled Al Awadi
 
Generic Protege Orientation
Generic Protege OrientationGeneric Protege Orientation
Generic Protege OrientationShamilla Essop
 
Signos De Puntuacion
Signos De PuntuacionSignos De Puntuacion
Signos De PuntuacionUpel
 
Exciting job opportunity: Prodev Group Holdings
Exciting job opportunity: Prodev Group HoldingsExciting job opportunity: Prodev Group Holdings
Exciting job opportunity: Prodev Group HoldingsFanisi_Capital
 
Архитектура текста
Архитектура текстаАрхитектура текста
Архитектура текстаsalunova
 

En vedette (12)

Para que se usan los blogs v1
Para que se usan los blogs v1Para que se usan los blogs v1
Para que se usan los blogs v1
 
Understanding Preferential Allotment of Securities
Understanding Preferential Allotment of SecuritiesUnderstanding Preferential Allotment of Securities
Understanding Preferential Allotment of Securities
 
Curriculum Vitae 10.02.15 sea service
Curriculum Vitae 10.02.15 sea serviceCurriculum Vitae 10.02.15 sea service
Curriculum Vitae 10.02.15 sea service
 
Kenexa style numerical test tutorial sample
Kenexa style numerical test tutorial sampleKenexa style numerical test tutorial sample
Kenexa style numerical test tutorial sample
 
New base 572 special 31 march 2015
New base 572 special 31 march  2015New base 572 special 31 march  2015
New base 572 special 31 march 2015
 
Generic Protege Orientation
Generic Protege OrientationGeneric Protege Orientation
Generic Protege Orientation
 
Reorganisation of the Einsiedeln Abbey Archives
Reorganisation of the Einsiedeln Abbey ArchivesReorganisation of the Einsiedeln Abbey Archives
Reorganisation of the Einsiedeln Abbey Archives
 
Signos De Puntuacion
Signos De PuntuacionSignos De Puntuacion
Signos De Puntuacion
 
Chapter 6_OM
Chapter 6_OMChapter 6_OM
Chapter 6_OM
 
Fake TOTAL job inv
Fake TOTAL job invFake TOTAL job inv
Fake TOTAL job inv
 
Exciting job opportunity: Prodev Group Holdings
Exciting job opportunity: Prodev Group HoldingsExciting job opportunity: Prodev Group Holdings
Exciting job opportunity: Prodev Group Holdings
 
Архитектура текста
Архитектура текстаАрхитектура текста
Архитектура текста
 

Plus de ReportLinker.com

Smartphones: When is the first and last time you check yours?
Smartphones: When is the first and last time you check yours?Smartphones: When is the first and last time you check yours?
Smartphones: When is the first and last time you check yours?ReportLinker.com
 
Interview Co-Founder ReportLinker and Findout, Benjamin Carpano
Interview Co-Founder ReportLinker and Findout, Benjamin CarpanoInterview Co-Founder ReportLinker and Findout, Benjamin Carpano
Interview Co-Founder ReportLinker and Findout, Benjamin CarpanoReportLinker.com
 
Tutorial for the ReportLinker App
Tutorial for the ReportLinker AppTutorial for the ReportLinker App
Tutorial for the ReportLinker AppReportLinker.com
 
Wireless Infrastructure: Market Shares, Strategies, and Forecasts, Worldwide,...
Wireless Infrastructure: Market Shares, Strategies, and Forecasts, Worldwide,...Wireless Infrastructure: Market Shares, Strategies, and Forecasts, Worldwide,...
Wireless Infrastructure: Market Shares, Strategies, and Forecasts, Worldwide,...ReportLinker.com
 
Global Electric Resistance Welded Pipes Industry
Global Electric Resistance Welded Pipes IndustryGlobal Electric Resistance Welded Pipes Industry
Global Electric Resistance Welded Pipes IndustryReportLinker.com
 
Global Wireless Gaming Industry
Global Wireless Gaming IndustryGlobal Wireless Gaming Industry
Global Wireless Gaming IndustryReportLinker.com
 
Hyperalgesia Global Clinical Trials Review, H1, 2013
Hyperalgesia Global Clinical Trials Review, H1, 2013Hyperalgesia Global Clinical Trials Review, H1, 2013
Hyperalgesia Global Clinical Trials Review, H1, 2013ReportLinker.com
 
Genital Herpes Global Clinical Trials Review, H1, 2013
Genital Herpes Global Clinical Trials Review, H1, 2013Genital Herpes Global Clinical Trials Review, H1, 2013
Genital Herpes Global Clinical Trials Review, H1, 2013ReportLinker.com
 
The Future of Direct Communications Technologies and Proximity-based Applicat...
The Future of Direct Communications Technologies and Proximity-based Applicat...The Future of Direct Communications Technologies and Proximity-based Applicat...
The Future of Direct Communications Technologies and Proximity-based Applicat...ReportLinker.com
 
Competing in the European Molecular Diagnostics Market: France, Germany, Ital...
Competing in the European Molecular Diagnostics Market: France, Germany, Ital...Competing in the European Molecular Diagnostics Market: France, Germany, Ital...
Competing in the European Molecular Diagnostics Market: France, Germany, Ital...ReportLinker.com
 
Competing in the European Clinical Chemistry and Immunodiagnostic Markets: Fr...
Competing in the European Clinical Chemistry and Immunodiagnostic Markets: Fr...Competing in the European Clinical Chemistry and Immunodiagnostic Markets: Fr...
Competing in the European Clinical Chemistry and Immunodiagnostic Markets: Fr...ReportLinker.com
 
Bradycardia Global Clinical Trials Review, H1, 2013
Bradycardia Global Clinical Trials Review, H1, 2013Bradycardia Global Clinical Trials Review, H1, 2013
Bradycardia Global Clinical Trials Review, H1, 2013ReportLinker.com
 
Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013
Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013
Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013ReportLinker.com
 
China iron ore mining industry, 2013
China iron ore mining industry, 2013China iron ore mining industry, 2013
China iron ore mining industry, 2013ReportLinker.com
 

Plus de ReportLinker.com (20)

Smartphones: When is the first and last time you check yours?
Smartphones: When is the first and last time you check yours?Smartphones: When is the first and last time you check yours?
Smartphones: When is the first and last time you check yours?
 
Interview Co-Founder ReportLinker and Findout, Benjamin Carpano
Interview Co-Founder ReportLinker and Findout, Benjamin CarpanoInterview Co-Founder ReportLinker and Findout, Benjamin Carpano
Interview Co-Founder ReportLinker and Findout, Benjamin Carpano
 
Tutorial for the ReportLinker App
Tutorial for the ReportLinker AppTutorial for the ReportLinker App
Tutorial for the ReportLinker App
 
Samsung customer loyalty
Samsung customer loyaltySamsung customer loyalty
Samsung customer loyalty
 
Project Caf
Project CafProject Caf
Project Caf
 
Project Caf
Project CafProject Caf
Project Caf
 
Wireless Infrastructure: Market Shares, Strategies, and Forecasts, Worldwide,...
Wireless Infrastructure: Market Shares, Strategies, and Forecasts, Worldwide,...Wireless Infrastructure: Market Shares, Strategies, and Forecasts, Worldwide,...
Wireless Infrastructure: Market Shares, Strategies, and Forecasts, Worldwide,...
 
 
 
Thisisatest
ThisisatestThisisatest
Thisisatest
 
Global Electric Resistance Welded Pipes Industry
Global Electric Resistance Welded Pipes IndustryGlobal Electric Resistance Welded Pipes Industry
Global Electric Resistance Welded Pipes Industry
 
Global Wireless Gaming Industry
Global Wireless Gaming IndustryGlobal Wireless Gaming Industry
Global Wireless Gaming Industry
 
Hyperalgesia Global Clinical Trials Review, H1, 2013
Hyperalgesia Global Clinical Trials Review, H1, 2013Hyperalgesia Global Clinical Trials Review, H1, 2013
Hyperalgesia Global Clinical Trials Review, H1, 2013
 
Genital Herpes Global Clinical Trials Review, H1, 2013
Genital Herpes Global Clinical Trials Review, H1, 2013Genital Herpes Global Clinical Trials Review, H1, 2013
Genital Herpes Global Clinical Trials Review, H1, 2013
 
The Future of Direct Communications Technologies and Proximity-based Applicat...
The Future of Direct Communications Technologies and Proximity-based Applicat...The Future of Direct Communications Technologies and Proximity-based Applicat...
The Future of Direct Communications Technologies and Proximity-based Applicat...
 
Competing in the European Molecular Diagnostics Market: France, Germany, Ital...
Competing in the European Molecular Diagnostics Market: France, Germany, Ital...Competing in the European Molecular Diagnostics Market: France, Germany, Ital...
Competing in the European Molecular Diagnostics Market: France, Germany, Ital...
 
Competing in the European Clinical Chemistry and Immunodiagnostic Markets: Fr...
Competing in the European Clinical Chemistry and Immunodiagnostic Markets: Fr...Competing in the European Clinical Chemistry and Immunodiagnostic Markets: Fr...
Competing in the European Clinical Chemistry and Immunodiagnostic Markets: Fr...
 
Bradycardia Global Clinical Trials Review, H1, 2013
Bradycardia Global Clinical Trials Review, H1, 2013Bradycardia Global Clinical Trials Review, H1, 2013
Bradycardia Global Clinical Trials Review, H1, 2013
 
Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013
Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013
Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013
 
China iron ore mining industry, 2013
China iron ore mining industry, 2013China iron ore mining industry, 2013
China iron ore mining industry, 2013
 

Epistem Holdings Plc ' Product Pipeline Review ' 2012

  • 1. Find Industry reports, Company profiles ReportLinker and Market Statistics >> Get this Report Now by email! Epistem Holdings Plc ' Product Pipeline Review ' 2012 Published on December 2012 Report Summary Epistem Holdings Plc ' Product Pipeline Review ' 2012 Summary Global Market Direct's pharmaceuticals report, "Epistem Holdings Plc - Product Pipeline Review - 2012" provides data on the Epistem Holdings Plc's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct's proprietary databases, Epistem Holdings Plc's corporate website, SEC filings, investor presentations and featured press releases, both from Epistem Holdings Plc and industry-specific third party sources, put together by Global Markets Direct's team. Scope - Epistem Holdings Plc - Brief Epistem Holdings Plc overview including business description, key information and facts, and its locations and subsidiaries. - Review of current pipeline of Epistem Holdings Plc human therapeutic division. - Overview of pipeline therapeutics across various therapy areas. - Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe. - Product profiles for late stage and clinical stage products of Epistem Holdings Plc with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones. - Recent updates of the Epistem Holdings Plc's pipeline in the last quarter. - Key discontinued and dormant projects. - Latest news and deals relating to the products. Reasons to buy - Evaluate Epistem Holdings Plc's strategic position with total access to detailed information on its product pipeline. - Assess the growth potential of Epistem Holdings Plc in its therapy areas of focus. - Identify new drug targets and therapeutic classes in the Epistem Holdings Plc's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas. - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps. - Exploit collaboration and partnership opportunities with Epistem Holdings Plc. - Avoid Intellectual Property Rights related issues. - Explore the dormant and discontinued projects of Epistem Holdings Plc and identify potential opportunities in those areas. Epistem Holdings Plc ' Product Pipeline Review ' 2012 (From Slideshare) Page 1/6
  • 2. Find Industry reports, Company profiles ReportLinker and Market Statistics >> Get this Report Now by email! Table of Content Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Epistem Holdings Plc Snapshot 5 Epistem Holdings Plc Overview 5 Key Information 5 Key Facts 5 Epistem Holdings Plc ' Research and Development Overview 6 Key Therapeutic Areas 6 Epistem Holdings Plc ' Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products ' Monotherapy 9 Epistem Holdings Plc ' Pipeline Products Glance 10 Epistem Holdings Plc ' Early Stage Pipeline Products 10 Pre-Clinical Products/Combination Treatment Modalities 10 Epistem Holdings Plc ' Drug Profiles 11 Epi-2221 11 Product Description 11 Mechanism of Action 11 R&D Progress 11 Epi-288 12 Product Description 12 Mechanism of Action 12 R&D Progress 12 Epi-3905 13 Product Description 13 Mechanism of Action 13 R&D Progress 13 Epi-6 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 Epistem Holdings Plc ' Pipeline Analysis 15 Epistem Holdings Plc ' Pipeline Products by Therapeutic Class 15 Epistem Holdings Plc ' Company Statement 16 Epistem Holdings Plc ' Locations And Subsidiaries 18 Head Office 18 Other Locations & Subsidiaries 18 Financial Deals Landscape 19 Epistem Holdings Plc, Deals Summary 19 Epistem Holdings Plc, Pharmaceuticals & Healthcare, Deal Details 20 Partnerships 20 Epistem Holdings Plc ' Product Pipeline Review ' 2012 (From Slideshare) Page 2/6
  • 3. Find Industry reports, Company profiles ReportLinker and Market Statistics >> Get this Report Now by email! Epistem Enters Into Distribution Agreement With Becton Dickinson For Mycobacterium TB Test 20 Epistem Holdings Enters Into Co-Development Agreement With GlaxoSmithKline 21 Epistem Holdings Enters Into Co-Marketing Agreement With Xcelris Labs For Molecular Tuberculosis Diagnostic Test 22 EpiStem Enters Into Research And Development Agreement With Novartis 23 Kyowa Hakko Kirin Enters Into Co-Development Agreement With Epistem 25 Equity Offering 26 Epistem Announces Private Placement Of Shares For $7 Million 26 Epistem Holdings Completes Private Placement Of Common Stock For $4.3 Million 28 Epistem Raises $5 Million In Private Financing 30 Epistem Holdings Completes Private Placement Of $2 Million 32 Epistem Holdings Completes IPO For $6.12 Million 34 Appendix 36 Methodology 36 Coverage 36 Secondary Research 36 Primary Research 36 Expert Panel Validation 36 Contact Us 37 Disclaimer 37 List of Tables Epistem Holdings Plc, Key Information 5 Epistem Holdings Plc, Key Facts 5 Epistem Holdings Plc ' Pipeline by Indication, 2012 7 Epistem Holdings Plc ' Pipeline by Stage of Development, 2012 8 Epistem Holdings Plc ' Monotherapy Products in Pipeline, 2012 9 Epistem Holdings Plc ' Pre-Clinical, 2012 10 Epistem Holdings Plc ' Pipeline By Therapeutic Class, 2012 15 Epistem Holdings Plc, Subsidiaries 18 Epistem Holdings Plc, Deals Summary 19 Epistem Enters Into Distribution Agreement With Becton Dickinson For Mycobacterium TB Test 20 Epistem Holdings Enters Into Co-Development Agreement With GlaxoSmithKline 21 Epistem Holdings Enters Into Co-Marketing Agreement With Xcelris Labs For Molecular Tuberculosis Diagnostic Test 22 EpiStem Enters Into Research And Development Agreement With Novartis 23 Kyowa Hakko Kirin Enters Into Co-Development Agreement With Epistem 25 Epistem Announces Private Placement Of Shares For $7 Million 26 Epistem Holdings Completes Private Placement Of Common Stock For $4.3 Million 28 Epistem Raises $5 Million In Private Financing 30 Epistem Holdings Completes Private Placement Of $2 Million 32 Epistem Holdings Completes IPO For $6.12 Million 34 List of Figures Epistem Holdings Plc ' Product Pipeline Review ' 2012 (From Slideshare) Page 3/6
  • 4. Find Industry reports, Company profiles ReportLinker and Market Statistics >> Get this Report Now by email! Epistem Holdings Plc ' Pipeline by Indication, 2012 7 Epistem Holdings Plc ' Pipeline by Stage of Development, 2012 8 Epistem Holdings Plc ' Monotherapy Products in Pipeline, 2012 9 Epistem Holdings Plc ' Pipeline By Therapeutic Class, 2012 15 Epistem Holdings Plc ' Product Pipeline Review ' 2012 (From Slideshare) Page 4/6
  • 5. Find Industry reports, Company profiles ReportLinker and Market Statistics >> Get this Report Now by email! Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to: Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93 If you have any questions please visit http://www.reportlinker.com/notify/contact Order Information Please verify that the product information is correct and select the format(s) you require. Epistem Holdings Plc ' Product Pipeline Review ' 2012 Product Formats Please select the product formats and the quantity you require. 1 User License--USD 1 500.00 Quantity: _____ Site License--USD 3 000.00 Quantity: _____ Corporate License--USD 4 500.00 Quantity: _____ Contact Information Please enter all the information below in BLOCK CAPITALS Title: Mr Mrs Dr Miss Ms Prof First Name: _____________________________ Last Name: __________________________________ Email Address: __________________________________________________________________________ Job Title: __________________________________________________________________________ Organization: __________________________________________________________________________ Address: __________________________________________________________________________ City: __________________________________________________________________________ Postal / Zip Code: __________________________________________________________________________ Country: __________________________________________________________________________ Phone Number: __________________________________________________________________________ Fax Number: __________________________________________________________________________ Epistem Holdings Plc ' Product Pipeline Review ' 2012 (From Slideshare) Page 5/6
  • 6. Find Industry reports, Company profiles ReportLinker and Market Statistics >> Get this Report Now by email! Payment Information Please indicate the payment method, you would like to use by selecting the appropriate box. Payment by credit card Card Number: ______________________________________________ Expiry Date __________ / _________ CVV Number _____________________ Card Type (ex: Visa, Amex…) _________________________________ Payment by wire transfer Crédit Mutuel RIB : 10278 07314 00020257701 89 BIC : CMCIFR2A IBAN : FR76 1027 8073 1400 0202 5770 189 Payment by check UBIQUICK SAS 16 rue Grenette – 69002 LYON, FRANCE Customer signature:   Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at http://www.reportlinker.com/index/terms Please fax this form to: Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93 Epistem Holdings Plc ' Product Pipeline Review ' 2012 (From Slideshare) Page 6/6